Browse Pet Safety Reports
16,682 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,682 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,682 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Oct 19, 2020 | Human | Unknown | Tilmicosin | Injection site bleeding; Localised pain NOS (see other 'SOCs' for specific pa... | Ongoing |
| Oct 19, 2020 | Human | Unknown | Ivermectin | Eye irritation; Dermatosis NOS; Burning sensation of eye | Recovered/Normal |
| Oct 18, 2020 | Human | Unknown | Tulathromycin | Localised rash; Numbness | Ongoing |
| Oct 17, 2020 | Human | Unknown | Selamectin | Hives (see also 'Skin'); Anaphylactic-type reaction | Ongoing |
| Oct 17, 2020 | Human | Unknown | Tulathromycin | Injection site irritation | Outcome Unknown |
| Oct 17, 2020 | Human | Unknown | Pirlimycin Hydrochloride | Eye irritation | Outcome Unknown |
| Oct 16, 2020 | Human | Unknown | Insulin Injectable Vial | Injection site bleeding; Accidental exposure; Drug administration error | Outcome Unknown |
| Oct 16, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Drug administration error | Recovered/Normal |
| Oct 16, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Drug administration error | Outcome Unknown |
| Oct 15, 2020 | Human | Unknown | Florfenicol, Terbinafine, Betamethaso... | Application site reddening; Application site irritation; Application site pai... | Outcome Unknown |
| Oct 13, 2020 | Human | Unknown | Flunixin Meglumine Injectable | Eye disorder NOS (for photophobia see 'neurological') | Ongoing |
| Oct 13, 2020 | Human | Unknown | Selamectin | Hives (see also 'Skin'); Anaphylactic-type reaction | Ongoing |
| Oct 12, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Throat irritation; Abdominal pain | Ongoing |
| Oct 11, 2020 | Human | Unknown | Afoxolaner | Hives (see also 'Skin'); Stinging skin; Rash; Environmental adverse event; An... | Outcome Unknown |
| Oct 10, 2020 | Human | Unknown | Tulathromycin | Application site reddening; Skin lesion NOS; Skin inflammation NOS | Outcome Unknown |
| Oct 10, 2020 | Human | Unknown | Tulathromycin | Puncture wound; Injection site bleeding; Injection site pain | Outcome Unknown |
| Oct 10, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Outcome Unknown |
| Oct 9, 2020 | Human | Unknown | Selamectin | Rash | Outcome Unknown |
| Oct 8, 2020 | Human | Unknown | Mirtazapine | Hypertension; Medication error | Outcome Unknown |
| Oct 8, 2020 | Human | Unknown | Pregnyl/Gestyl 200/400 | Injection site bleeding | Outcome Unknown |
| Oct 7, 2020 | Human | Unknown | Selamectin | Hives (see also 'Skin'); Pruritus; Localised oedema (not application site); A... | Ongoing |
| Oct 5, 2020 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Eye irritation | Outcome Unknown |
| Oct 5, 2020 | Human | Unknown | Maropitant Citrate | Puncture wound; Injection site numbness | Recovered/Normal |
| Oct 2, 2020 | Human | Unknown | Selamectin | Eye irritation; Accidental exposure | Outcome Unknown |
| Oct 2, 2020 | Human | Unknown | Meloxicam | Bloodshot eye; Vision blurred | Recovered/Normal |
| Oct 2, 2020 | Human | Unknown | Dexmedetomidine Hydrochloride | Eyelid oedema; Erythema (for urticaria see Immune SOC); Burning sensation (skin) | Outcome Unknown |
| Oct 1, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Application site residue; Drug administrati... | Recovered/Normal |
| Sep 30, 2020 | Human | Unknown | Cefovecin | Puncture wound; Injection site pain | Outcome Unknown |
| Sep 30, 2020 | Human | Unknown | Milbemycin/Lufenuron Tablets | Nausea; Medication error; Accidental exposure | Ongoing |
| Sep 30, 2020 | Human | Unknown | Gonadotropin Releasing Factor (Gnrf) ... | Puncture wound | Recovered/Normal |
| Sep 30, 2020 | Human | Unknown | Mirtazapine | Erythematous rash; Other ear disorder NOS | Outcome Unknown |
| Sep 29, 2020 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Burning sensation of eye | Outcome Unknown |
| Sep 29, 2020 | Human | Unknown | Alfaxalone | Injection site numbness; Tiredness; Injection site tingling | Recovered/Normal |
| Sep 28, 2020 | Human | Unknown | Selamectin | Application site reaction NOS | Outcome Unknown |
| Sep 28, 2020 | Human | Unknown | Fluralaner Spot-On Solution | Hives (see also 'Skin'); Throat tingling; Anaphylactic-type reaction | Recovered/Normal |
| Sep 27, 2020 | Human | Unknown | Lotilaner | Vomiting; Accidental exposure | Recovered/Normal |
| Sep 24, 2020 | Human | Unknown | Salicylic Acid; Phytosphingosine Hydr... | Tongue disorder NOS | Ongoing |
| Sep 21, 2020 | Human | Unknown | Selamectin | Erythematous rash; Localised itching; Local swelling (not application site); ... | Recovered/Normal |
| Sep 21, 2020 | Human | Unknown | Isoflurane | Accidental exposure; Containers, Damaged; No sign | Recovered/Normal |
| Sep 20, 2020 | Human | Unknown | Imidacloprid; Moxidectin | Anxious state of mind; Dry mouth | Recovered/Normal |
| Sep 19, 2020 | Human | Unknown | Trilostane | Skin disorders NOS | Outcome Unknown |
| Sep 18, 2020 | Human | Unknown | Ceftiofur Crystalline Free Acid | Injection site pain | Outcome Unknown |
| Sep 17, 2020 | Human | Unknown | Tilmicosin | Injection site bleeding; Dizziness; Injection site pain | Recovered/Normal |
| Sep 17, 2020 | Human | Unknown | Thiamazole | Localised pain NOS (see other 'SOCs' for specific pain); Drug administration ... | Outcome Unknown |
| Sep 16, 2020 | Human | Unknown | Tulathromycin | Injection site swelling; Injection site pain | Outcome Unknown |
| Sep 16, 2020 | Human | Unknown | Praziquantel; Febantel; Pyrantel | Numbness; Accidental exposure | Outcome Unknown |
| Sep 14, 2020 | Human | Unknown | Phytosphingosine Salicyloyl; Chlorhex... | Application site rash | Ongoing |
| Sep 14, 2020 | Human | Unknown | Selamectin;Sarolaner | Ocular burn | Recovered/Normal |
| Sep 12, 2020 | Human | Unknown | Insulin Injectable Vial | Nausea; Accidental exposure; Drug administration error | Ongoing |
| Sep 11, 2020 | Human | Unknown | Dexmedetomidine Hydrochloride | Drowsiness - systemic disorder | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.